Trails Edge Capital Partners, LP

Q3 2026 13F-HR Holdings

Location
Atlanta, GA
Holdings as of
9/30/2026
Date filed
11/16/2026
Form type
13F-HR
Num holdings
38
Total value ($000)
$695,902
Net value change ($000)
+65,990 (10.5%)
New positions
9
Sold out positions
6
Turnover %
41.1%
Sector allocation + QoQ delta (equities-only)

Snapshot: Change Analysis

Compared to Q2 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
OBSIDIAN THERAPEUTICS INC 34,265 NEW
TNGX 27,445 NEW
CLDX 24,794 NEW
CTNM 22,729 NEW
TYRA 21,870 NEW
INBX 17,014 NEW
SNSE 15,123 117.4%
BMRN 10,723 36.6%
TRDA 9,071 NEW
AVTX 6,513 39.5%
Top Reduces (Value $000, Stocks/ETFs)
MIRM -26,143 -100.0%
INSM -24,558 -100.0%
SNDX -24,265 -100.0%
RVMD -21,678 -100.0%
INCY -17,571 -100.0%
XENE -11,682 -44.0%
KAILERA THERAPEUTICS INC -10,926 -50.4%
FBRX -5,805 -100.0%
LBRX -5,322 -10.8%
OKUR -4,871 -74.3%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type